Alain Garnier

2.4k total citations
71 papers, 1.9k citations indexed

About

Alain Garnier is a scholar working on Molecular Biology, Genetics and Biomedical Engineering. According to data from OpenAlex, Alain Garnier has authored 71 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Molecular Biology, 22 papers in Genetics and 13 papers in Biomedical Engineering. Recurrent topics in Alain Garnier's work include Virus-based gene therapy research (20 papers), Viral Infectious Diseases and Gene Expression in Insects (19 papers) and Enzyme Catalysis and Immobilization (9 papers). Alain Garnier is often cited by papers focused on Virus-based gene therapy research (20 papers), Viral Infectious Diseases and Gene Expression in Insects (19 papers) and Enzyme Catalysis and Immobilization (9 papers). Alain Garnier collaborates with scholars based in Canada, United States and Spain. Alain Garnier's co-authors include Amine Kamen, María Mercedes Segura, Bernard Massie, Bruno Gaillet, Johanne Côté, Nicolas Pineault, Carl Duchesne, Yves Durocher, Maria C. Iliuta and Pierre Trudel and has published in prestigious journals such as PLoS ONE, Biomaterials and Journal of Virology.

In The Last Decade

Alain Garnier

69 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alain Garnier Canada 27 1.1k 726 260 228 207 71 1.9k
Mao Chen China 32 2.4k 2.1× 589 0.8× 211 0.8× 122 0.5× 246 1.2× 100 3.6k
Cristina Peixoto Portugal 28 1.8k 1.6× 1.0k 1.4× 561 2.2× 321 1.4× 225 1.1× 90 2.9k
Satyendra Kumar Singh India 27 2.1k 1.8× 563 0.8× 121 0.5× 88 0.4× 414 2.0× 140 3.1k
Kiyoshi Ito Japan 28 1.4k 1.2× 282 0.4× 146 0.6× 201 0.9× 449 2.2× 167 3.2k
Takashi Horiuchi Japan 35 3.2k 2.8× 1.3k 1.8× 72 0.3× 174 0.8× 361 1.7× 162 4.4k
K B Myambo United States 8 1.7k 1.4× 840 1.2× 71 0.3× 306 1.3× 293 1.4× 9 2.6k
Lilit Garibyan United States 21 567 0.5× 512 0.7× 135 0.5× 154 0.7× 363 1.8× 59 2.4k
Wei‐Shou Hu United States 31 2.0k 1.7× 454 0.6× 72 0.3× 625 2.7× 172 0.8× 88 3.1k
David A. Lucas United States 25 1.4k 1.2× 104 0.1× 145 0.6× 164 0.7× 179 0.9× 35 2.2k
Xin Ye China 24 1.6k 1.4× 229 0.3× 129 0.5× 378 1.7× 475 2.3× 64 2.4k

Countries citing papers authored by Alain Garnier

Since Specialization
Citations

This map shows the geographic impact of Alain Garnier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alain Garnier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alain Garnier more than expected).

Fields of papers citing papers by Alain Garnier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alain Garnier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alain Garnier. The network helps show where Alain Garnier may publish in the future.

Co-authorship network of co-authors of Alain Garnier

This figure shows the co-authorship network connecting the top 25 collaborators of Alain Garnier. A scholar is included among the top collaborators of Alain Garnier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alain Garnier. Alain Garnier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Barra, Lillian, Guillaume Paré, Halim Maaroufi, et al.. (2025). Identification of autoantibodies targeting citrullinated CLEC12A in rheumatoid arthritis patients. Journal of Translational Autoimmunity. 10. 100287–100287.
2.
Chahal, Parminder S., et al.. (2023). Purification of recombinant vesicular stomatitis virus-based HIV vaccine candidate. Vaccine. 41(13). 2198–2207. 3 indexed citations
3.
Gélinas, Jean‐François, Hiva Azizi, Sascha Kießlich, et al.. (2020). Evaluation of novel HIV vaccine candidates using recombinant vesicular stomatitis virus vector produced in serum-free Vero cell cultures. Vaccine. 38(50). 7949–7955. 8 indexed citations
4.
Hoesli, Corinne A., Catherine Tremblay, Bruno Gaillet, et al.. (2018). Dynamics of Endothelial Cell Responses to Laminar Shear Stress on Surfaces Functionalized with Fibronectin-Derived Peptides. ACS Biomaterials Science & Engineering. 4(11). 3779–3791. 13 indexed citations
5.
Hoesli, Corinne A., et al.. (2013). A fluorophore-tagged RGD peptide to control endothelial cell adhesion to micropatterned surfaces. Biomaterials. 35(3). 879–890. 38 indexed citations
6.
7.
Duchesne, Carl, et al.. (2012). Single-cell level analysis of megakaryocyte growth and development. Differentiation. 83(4). 200–209. 14 indexed citations
8.
Segura, María Mercedes, Amine Kamen, & Alain Garnier. (2011). Overview of Current Scalable Methods for Purification of Viral Vectors. Methods in molecular biology. 737. 89–116. 60 indexed citations
9.
Robert, Amélie, et al.. (2010). Polyploid megakaryocytes can complete cytokinesis. Cell Cycle. 9(13). 2589–2599. 20 indexed citations
10.
Segura, María Mercedes, Alain Garnier, Yves Durocher, Sven Ansorge, & Amine Kamen. (2009). New Protocol for Lentiviral Vector Mass Production. Methods in molecular biology. 614. 39–52. 32 indexed citations
11.
Caron, Antoine W., Bruno Gaillet, Maxime Pinard, et al.. (2009). Fluorescent labeling in semi-solid medium for selection of mammalian cells secreting high-levels of recombinant proteins. BMC Biotechnology. 9(1). 42–42. 30 indexed citations
12.
Pineault, Nicolas, et al.. (2008). Ex Vivo Megakaryocyte Expansion and Platelet Production from Human Cord Blood Stem Cells. Methods in molecular biology. 482. 109–126. 18 indexed citations
13.
Segura, María Mercedes, et al.. (2007). Production of lentiviral vectors by large‐scale transient transfection of suspension cultures and affinity chromatography purification. Biotechnology and Bioengineering. 98(4). 789–799. 106 indexed citations
14.
Kamen, Amine, et al.. (2006). Exploiting heparin-binding properties of MoMLV-based retroviral vectors for affinity chromatography. Journal of Chromatography B. 846(1-2). 124–131. 14 indexed citations
15.
Paradis‐Bleau, Catherine, et al.. (2006). Peptidoglycan lytic activity of thePseudomonas aeruginosaphage ÏKZ gp144 lytic transglycosylase. FEMS Microbiology Letters. 266(2). 201–209. 42 indexed citations
16.
Kamen, Amine, et al.. (2005). A novel purification strategy for retrovirus gene therapy vectors using heparin affinity chromatography. Biotechnology and Bioengineering. 90(4). 391–404. 78 indexed citations
17.
Garnier, Alain, et al.. (2003). pH, pCO 2 , and Temperature Effect on R‐Adenovirus Production. Biotechnology Progress. 19(1). 202–208. 33 indexed citations
18.
Havugimana, Pierre C., et al.. (2001). In vitro reconstruction of the biosynthetic pathway of peptidoglycan cytoplasmic precursor in Pseudomonas aeruginosa. FEMS Microbiology Letters. 201(2). 229–235. 37 indexed citations
19.
Tremblay, Jacques P., et al.. (2001). Scale-up of a myoblast culture process. Journal of Biotechnology. 91(1). 63–74. 27 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026